Nuplex boosts FY guidance for fourth time
Nuplex Industries, the resins maker that announced a first-half profit of $34.6 million January, has boosted its full-year guidance for the fourth time as the price of raw materials increases.
The specialty chemicals manufacturer announced an earnings before interest, taxation, depreciation and amortisation forecast of $125 million to $135 million, or 30 to 36 cents per share, in its first-half report ended December 31. That’s $5 million more than the range of $120 million to $135 million, announced in its January first-half result statement.
Chairman Rob Aitken said demand is recovering from the low point of the last financial year, but is still below the peak levels of 2007/2008.
“Nuplex is in a strong position,” he said in the first-half report. “We have a sound balance sheet and a good cash flow.”
Over the past year, the company undertook a major restructure, including selling shares at a deep discount, and introduced tight cost controls after a dwindling kiwi dollar drove the cost of its overseas debt amid falling demand for its products. Since then, they have posted a first-half profit of $34.6 million as demand out of Asia underpinned increased revenues.
The shares gained 2.4% to $3.40 in trading today, and have surged 334% over the past year. They are rated a ‘outperform’, according to a Reuters survey of six analysts.
Rising prices for raw material prices over the past four years makes the company confident, especially in Asia, which takes up 19% of the regional sales. The region is “performing strongly,” according to Aitken.
Earlier today, Nuplex announced the purchase of the ingredients business of Med-Chem group, which distributes medical and surgical equipment. Though the price wasn’t revealed, Nuplex said buying the group would lift earnings for its specialties unit by 15% for the first year.
Businesswire.co.nz
Comments from our readers
No comments yet Add your comment:
Related News
Nuplex enters Russian joint venture Nuplex shares plunge 7.8% after profit warning Nuplex gains regulatory approval for Viverso purchase Nuplex may replace some bank debt with first issue of bonds in US private placement market Nuplex to buy Bayer MaterialScience's Viverso, forecasts 10% earnings growth Nuplex bows to shareholder pressure, withdraws director fee hike proposal Nuplex directors ask for shareholders for 33% pay rise Nuplex pays A$23.5 mln for Acquo Masterbatch Nuplex full year profit up 7.5 pct Daily ShareChat: Nuplex
NZX Annoucements for NPX
|
|
Nuplex Industries Limited Ordinary Shares
Current quote:
NPX $2.61 +1
Quotes delayed 20 minutes
Price when article published: $3.41
Previous News
FREE Email News
Stock Quote
Today's Market Numbers
| NZX 50 Index |
3326.74 |
 |
2.10 |
| S&P/ASX 200 |
4282.90 |
 |
7.80 |
| Dow Jones Industrials |
12884.00 |
 |
5.80 |
Most Commented On
|
|


NZX 15 Index
|